Office of Health Economics on Twitter: “Each year we offer 2 students the opportunity to join our …

from Google Alert at https://www.google.com/url?rct=j&sa=t&url=https://mobile.twitter.com/OHENews/status/1519271453442592771&ct=ga&cd=CAIyHjNjYTgyMDdhZjIwYWZhOWM6Y28udWs6ZW46R0I6TA&usg=AOvVaw26786TEXcGGOtOF4zsqDmM on July 30, 2022 at 06:45AM Each year we offer 2 students the opportunity to join our team alongside a part-time MSc in health economics at City, University.

Links

from Healthcare Economist at https://bit.ly/3zINSLX on July 29, 2022 at 11:44PM Rare disease burden 10x standard disease. The value of empathy. ACA and political adverse selection Are HDHPs obsolete? Are too many antibiotics prescribed due to fear of malpractice?

Strategies for Maximizing Policy Impact

from AcademyHealth Blog at https://bit.ly/3zFxhZk on July 29, 2022 at 04:55PM Strategies for Maximizing Policy Impact Panelists at the 2022 AcademyHealth Annual Research Meeting (ARM), including moderator Dr. Claire Brindis of the University of California, San Francisco, Drs. Arrianna Marie Planey, Kellan Baker, Janet Coffman, and Abdul Shaikh spoke about the various ways health service […]

Against patents, again (3)

from Econsalut at https://bit.ly/3zHdLf1 on July 29, 2022 at 12:08PM  Patent Politics. Life Forms, Markets, and the Public Interest in the United States and Europe Comparing battles over patents on animals, human embryonic stem cells, human genes, and plants in the United States and Europe, she shows how political culture, ideology, and history shape patent […]

Against patents (2)

from Econsalut at https://bit.ly/3zDFeyi on July 29, 2022 at 12:08PM  Medical Monopoly. Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry Medical Monopoly combines legal, medical, and business history to offer a sweeping new interpretation of the origins of the complex and often troubling relationship between the pharmaceutical industry and medical practice today. […]